microdosing glp 1 dr tyna Is “Microdosing” Semaglutide the Future of Personalized Metabolic Care? Microdosing GLP-1s: How (and Why)

Willow does not require lab work to begin treatment

Read the call transcript carefully and you find a company whose CFO is explaining why same-club sales should decelerate to 4-5% in 2026 (an extended equipment replacement cycle plus the sale of eight California corporate clubs to franchisees), and whose CEO is using nearly all of her airtime to talk about positioning the chain at the center of a metabolic-health movement

These medicines often called GLP-1 medications have become much more common over the past few years

GLP-1 is the same hormone mimicked by blockbuster drugs like Ozempic and Mounjaro

Retatrutides prescription availability in Canada is projected to follow Phase 3 trial completion and regulatory review, likely beginning in 2026 at the earliest

The threshold increase is precautionary